Aeluma, INC Form 4 insider transactions

Aeluma, Inc. Director and CEO Jonathan Klamkin sold a total of 18,900 shares of common stock on June 1, 2026, under a pre-arranged Rule 10b5-1 trading plan.

Director Steven Denbaars sold 25,000 shares of Aeluma, Inc. common stock via a pre-arranged Rule 10b5-1 trading plan.

Aeluma, Inc. CEO Jonathan Klamkin reported a series of stock transfers to a family trust and subsequent sales under a Rule 10b5-1 trading plan.

Jonathan Klamkin, CEO and Director of Aeluma, Inc., reported the sale of 20,000 common shares for approximately $261,940 under a pre-established Rule 10b5-1 trading plan.

Aeluma, Inc. CEO Jonathan Klamkin reported the sale of 50,000 shares of common stock on March 4, 2026, executed under a pre-arranged Rule 10b5-1 trading plan.

Aeluma, Inc. Director Craig H. Ensley was granted 10,633 shares of common stock as restricted stock units on December 3, 2025, increasing his direct beneficial ownership to 27,300 shares.

Aeluma, Inc. Director John Kenneth Paglia acquired 10,861 common shares through a restricted stock unit grant, increasing his direct beneficial ownership to 23,361 shares.

Aeluma, Inc. Director Michael Byron reported the acquisition of 13,343 restricted stock units and 3,653 fully vested stock options.

Aeluma, Inc. Director Steven Denbaars acquired 10,121 shares of common stock through a restricted stock unit grant.

Aeluma, Inc. Director Steven Denbaars reported the sale of 25,000 shares of common stock over two days in late February 2026, executed under a pre-established 10b5-1 trading plan.

Mark N. Tompkins, a former 10% owner of Aeluma, Inc., reported selling 34,500 shares of common stock on February 4, 2026, ceasing to be a 10% beneficial owner.

Aeluma, Inc. Director and 10% owner Mark N. Tompkins reported selling 95,000 shares of common stock across multiple transactions in late January and early February 2026.

Mark N. Tompkins, a Director and 10% Owner of Aeluma, Inc. (ALMU), sold 105,000 shares of common stock across multiple transactions from January 20-22, 2026, under a pre-arranged trading plan.

Lee McCarthy, former COO and interim CFO of Aeluma, Inc., sold 649,570 unvested common shares back to the company following his resignation, reducing his ownership to 8.03%.

Aeluma, Inc. Director and 10% owner Mark N. Tompkins sold 60,000 shares of common stock across multiple transactions in late December 2025 under a pre-arranged trading plan.

Aeluma, Inc. Director and 10% owner Mark N. Tompkins sold 85,000 shares of common stock over three days in December 2025 under a Rule 10b5-1 plan.

Aeluma, Inc. Director and 10% owner Mark N. Tompkins reported the sale of 50,000 shares of common stock over two days in December 2025.

Aeluma Inc.'s Director and 10% Owner, Mark N. Tompkins, reported selling 100,000 shares of common stock over several transactions in early December 2025.

Aeluma, Inc. Director and 10% owner Mark N. Tompkins sold a total of 77,500 shares of common stock for approximately $1.29 million in pre-planned transactions.

Mark N. Tompkins, a Director and 10% owner of Aeluma, Inc., reported the sale of 65,000 shares of common stock over two days in October 2025.

Aeluma Inc. Director and 10% owner Mark N. Tompkins sold approximately $1.9 million worth of common stock over several transactions.

Aeluma Director and 10% owner Mark N. Tompkins sold 106,908 shares of common stock for approximately $1.84 million across multiple transactions in October 2025.

Aeluma, Inc. Director and 10% owner Mark N. Tompkins sold a total of 129,751 shares of common stock over several transactions in early October 2025.

Aeluma Director Mark N. Tompkins filed an amended Form 4 to correct the number of shares sold in a recent transaction.

Aeluma, Inc. Director and 10% owner Mark N. Tompkins reported selling 109,080 shares of common stock over several transactions in late September and early October 2025.

Aeluma, Inc. CEO Jonathan Klamkin sold 150,000 shares of common stock and amended a previous filing to clarify the nature of the transaction.

Aeluma, Inc. CEO Jonathan Klamkin sold 150,000 shares of common stock for approximately $2.83 million after receiving a bonus grant of restricted stock units and stock options.

Aeluma, Inc. Director and 10% Owner Steven Denbaars reported the acquisition of 84,663 stock options at an exercise price of $7.8 per share, effective January 10, 2025.

Aeluma, Inc. Director John Kenneth Paglia was granted 87,973 stock options with an exercise price of $7.80 per share, aligning his interests with shareholder value.

Aeluma, Inc. Director Craig H. Ensley has reported the acquisition of 85,885 stock options at an exercise price of $7.8 per share, increasing his beneficial ownership of derivative securities.